Serum (1→3)-β-D-Glucan measurement for the diagnosis of Pneumocystis jirovecii pneumonia and its usefulness for monitoring treatment efficiency

J. Held, M.-S. Koch, D. Wagner & A. Serr
Pneumocystis jirovecii pneumonia (PJP) is a major cause of illness and death in immunocompromised individuals. Therefore early detection and therapy is vital in reducing mortality. After initiation of treatment the patient's condition should start to improve after at least 7 days. Otherwise resistance[for full text, please go to the a.m. URL]